KR20230050829A - A composition for prevention or improvement of hair loss comprising setaria italica beauv. extract - Google Patents
A composition for prevention or improvement of hair loss comprising setaria italica beauv. extract Download PDFInfo
- Publication number
- KR20230050829A KR20230050829A KR1020210134094A KR20210134094A KR20230050829A KR 20230050829 A KR20230050829 A KR 20230050829A KR 1020210134094 A KR1020210134094 A KR 1020210134094A KR 20210134094 A KR20210134094 A KR 20210134094A KR 20230050829 A KR20230050829 A KR 20230050829A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- perilla
- samda
- hair loss
- dermal papilla
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 61
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 40
- 208000024963 hair loss Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 230000003676 hair loss Effects 0.000 title claims abstract description 25
- 230000006872 improvement Effects 0.000 title claims abstract description 10
- 230000002265 prevention Effects 0.000 title claims abstract description 8
- 240000005498 Setaria italica Species 0.000 title description 3
- 235000007226 Setaria italica Nutrition 0.000 title description 3
- 230000002500 effect on skin Effects 0.000 claims abstract description 63
- 230000035755 proliferation Effects 0.000 claims abstract description 25
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 51
- 235000004347 Perilla Nutrition 0.000 claims description 50
- 239000000469 ethanolic extract Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000002537 cosmetic Substances 0.000 claims description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 17
- 239000002021 butanolic extract Substances 0.000 claims description 16
- 230000003752 improving hair Effects 0.000 claims description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 241000195493 Cryptophyta Species 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 241000218645 Cedrus Species 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 235000005775 Setaria Nutrition 0.000 abstract 2
- 241000232088 Setaria <nematode> Species 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 45
- 230000000694 effects Effects 0.000 description 36
- 230000004663 cell proliferation Effects 0.000 description 28
- 210000004209 hair Anatomy 0.000 description 23
- 239000013641 positive control Substances 0.000 description 14
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 13
- 229960003632 minoxidil Drugs 0.000 description 12
- 239000002035 hexane extract Substances 0.000 description 10
- 230000002062 proliferating effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000002026 chloroform extract Substances 0.000 description 8
- 239000002024 ethyl acetate extract Substances 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000019439 ethyl acetate Nutrition 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 3
- 230000031774 hair cycle Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012454 non-polar solvent Substances 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 210000003135 vibrissae Anatomy 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229960004199 dutasteride Drugs 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- -1 etc.) Chemical compound 0.000 description 2
- 229960004039 finasteride Drugs 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940054749 avodart Drugs 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 239000004036 potassium channel stimulating agent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940117382 propecia Drugs 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229940107889 rogaine Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 201000001297 telogen effluvium Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 삼다차조 추출물을 포함하는 탈모의 예방 또는 개선을 위한 조성물에 관한 것이다. 구체적으로, 본 발명은 삼다차조 추출물을 유효성분으로 포함하는, 모유두 세포의 증식을 증가시켜 탈모를 예방 또는 개선하기 위한 화장료 조성물에 관한 것이다.The present invention relates to a composition for preventing or improving hair loss containing an extract of cedar algae. Specifically, the present invention relates to a cosmetic composition for preventing or improving hair loss by increasing the proliferation of dermal papilla cells, comprising a Samda perilla extract as an active ingredient.
모유두 세포는 모발의 발생과 성장을 담당하는 핵심 세포로, 모발의 피하에 있는 뿌리인 모근의 가장 밑부분에 위치한다. 실제로 두피에서 모유두 세포를 채집해 배양 후 이식할 경우 모발이 새로 자라난다. 하지만 모유두 세포를 탈모 치료제로 사용하기에는 여러 어려움이 존재한다. 우선 두피로부터의 분리가 어렵고, 배양 조건이 까다로우며 충분한 양의 세포를 배양하는 것이 어렵다. 또한 많이 배양할 경우 모발 재생 능력이 현저히 저하되는 한계가 있다.Dermal papilla cells are key cells responsible for the development and growth of hair, and are located at the bottom of the hair root, which is the root of the hair subcutaneously. In fact, when dermal papilla cells are collected from the scalp, cultured, and transplanted, new hair grows. However, there are several difficulties in using dermal papilla cells as a hair loss treatment. First, it is difficult to separate from the scalp, the culture conditions are difficult, and it is difficult to culture a sufficient amount of cells. In addition, when cultured a lot, there is a limit in that the hair regeneration ability is significantly lowered.
사람의 모발은 일정한 모발 성장주기 (hair growth cycle)를 가지고 있기 때문에 항상 일정한 수의 모발을 유지하게 된다. 그러나 탈모가 진행되면 모근에 존재하는 모유두가 작아지고, 모유두가 작아지면 머리털의 굵기가 가늘어지고, 동시에 모발 성장주기도 짧아진다. 따라서 탈모가 진행되면 머리털은 매우 가늘어지며 모발 성장주기는 더욱 짧아져 조금 자란 후 빠지게 된다.Since human hair has a certain hair growth cycle, a certain number of hairs is always maintained. However, as hair loss progresses, the dermal papilla present in the hair root becomes smaller, and when the dermal papilla becomes smaller, the thickness of the hair becomes thinner, and at the same time, the hair growth cycle is shortened. Therefore, as hair loss progresses, the hair becomes very thin and the hair growth cycle becomes shorter, so it grows a little and then falls out.
탈모의 원인으로는 유전적인 원인, 남성호르몬의 작용뿐만 아니라 내분비 질환, 영양 결핍, 약물 사용, 출산, 발열, 수술 등의 심한 신체적, 정신적 스트레스 등의 요인들이 복합적으로 작용하는 것으로 알려져 있다. 최근에는 남성형 탈모뿐만 아니라 식생활의 변화, 사회 환경 등에 의한 스트레스의 증가로 인해 여성의 탈모 인구도 증가하고 있는 추세이며, 연령 또한 낮아지고 있다.It is known that the cause of hair loss is a combination of factors such as genetic causes and male hormones, as well as severe physical and mental stress such as endocrine diseases, nutritional deficiencies, drug use, childbirth, fever, and surgery. In recent years, not only male pattern baldness, but also the trend of increasing the female hair loss population due to changes in dietary life, increase in stress due to social environment, etc., and the age is also getting lower.
현재 가장 빈번하게 쓰이는 탈모 치료제로는 피나스테라이드 (finasteride; 상품명 Propecia®), 두타스테라이드 (dutasteride; 상품명 Avodart®), 미녹시딜 (minoxidil; 상품명 마이녹실® 또는 Rogaine®) 등이 있다. 피나스테라이드와 두타스테라이드는 5α-환원효소 억제제 (5α-reductase inhibitor)로 남성호르몬 (testosterone)이 5α-dihydrotestosterone (DHT)로 전환되는 것을 억제한다. 그러나 이 제품은 성욕감퇴, 발기부전, 운전 및 수행능력 상실 등의 부작용을 나타낸다. 한편 미녹시딜의 경우 아직까지 그 기전이 완벽히 밝혀지지 않았으나, 세포막을 과분극 (hyperpolarization)시키는 칼륨 채널 개방제 (potassium chaennel opener)로서, 혈관 확장 및 칼륨 채널 개방을 통해, 모낭에 산소, 혈액, 영양소 등의 공급을 증가시켜 모낭을 건강하게 하는 것으로 여겨지고 있다. 그러나 이 제품 역시 도포 부위의 가려움, 홍반, 피부 자극, 눈의 자극 등의 부작용이 나타나며, 머리 이외에 다른 신체 부위에서의 원치 않는 모발의 성장이 관찰되기도 한다. 이러한 기존 제품들의 부작용은 환자들의 불안감을 증폭시키고 심할 경우 투여 거부까지 이어질 수 있기 때문에 부작용이 적은 약물을 개발하려는 노력이 계속되고 있다.Currently, the most frequently used hair loss treatments include finasteride (trade name Propecia®), dutasteride (trade name Avodart®), and minoxidil (trade name Minoxidil® or Rogaine®). Finasteride and dutasteride are 5α-reductase inhibitors that inhibit the conversion of testosterone to 5α-dihydrotestosterone (DHT). However, this product shows side effects such as decreased libido, erectile dysfunction, and loss of ability to drive and perform. On the other hand, in the case of minoxidil, its mechanism has not yet been fully elucidated, but as a potassium channel opener that hyperpolarizes cell membranes, it expands blood vessels and opens potassium channels, thereby providing oxygen, blood, and nutrients to hair follicles. It is believed to make hair follicles healthy by increasing their supply. However, this product also has side effects such as itchiness, erythema, skin irritation, and eye irritation at the application site, and unwanted hair growth in other parts of the body other than the head is sometimes observed. Since the side effects of these existing products can amplify patients' anxiety and lead to refusal of administration in severe cases, efforts to develop drugs with fewer side effects are continuing.
한편, 삼다차조는 제주지역 토종 차조로, 곡물인 조 (Setaria italica)의 품종의 일종이다. 한국 등록특허공보 제10-2150927호에 삼다차조 혼합 추출물의 항염 효과, 피부 보습 효과, 피부 장벽 강화 효과 및 아토피 개선 효과를 개시하고 있으나, 삼다차조 추출물의 탈모 개선 효과에 대해서 전혀 개시되어 있지 않다.On the other hand, Samdachajo is a native Jeju region, and is a kind of grain of millet ( Setaria italica ). Korean Patent Registration No. 10-2150927 discloses the anti-inflammatory effect, skin moisturizing effect, skin barrier strengthening effect, and atopic improvement effect of the mixed extract of Samdachacha extract, but the hair loss improvement effect of the Samdachacho extract is not disclosed at all.
따라서, 본 발명자들은 부작용이 적으면서 우수한 탈모의 예방 및 치료 효과를 갖는 물질을 연구하는 과정에서 삼다차조 추출물이 모유두 세포를 증식하는 효능을 갖는 것을 발견하여 본 발명을 완성하였다.Therefore, the inventors of the present invention completed the present invention by discovering that the Samda perilla extract has an effect of proliferating dermal papilla cells in the process of researching a substance having excellent preventive and therapeutic effects on hair loss with few side effects.
본 발명은 삼다차조 추출물을 포함하는 탈모의 예방 또는 개선을 위한 화장료 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a cosmetic composition for preventing or improving hair loss containing an extract of cedar algae.
본 발명은 삼다차조 추출물을 포함하는 탈모의 예방 또는 개선을 위한 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for preventing or improving hair loss containing an extract of cedar algae.
상기 삼다차조 추출물은 물, C1 내지 C6의 알코올, 에틸아세테이트, 헥산, 클로로포름, 및 이들의 혼합 용매로 이루어지는 군으로부터 선택되는 용매로 추출될 수 있으며, 이에 제한되지 않는다.The Samdachajo extract may be extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, ethyl acetate, hexane, chloroform, and mixed solvents thereof, but is not limited thereto.
바람직하게, 본 발명의 삼다차조 추출물은 0.01% 내지 90% 에탄올 추출물 또는 부탄올 추출물일수 있으며, 더욱 바람직하게 본 발명의 삼다차조 추출물은 60% 내지 80% 에탄올 추출물 또는 부탄올 추출물일 수 있고, 가장 바람직하게 본 발명의 삼다차조 추출물은 70% 에탄올 추출물 또는 부탄올 추출물일 수 있다.Preferably, the Samda perilla extract of the present invention may be a 0.01% to 90% ethanol extract or a butanol extract, more preferably, the Samda perilla extract of the present invention may be a 60% to 80% ethanol extract or a butanol extract, and most preferably The extract of Samdachajo of the present invention may be a 70% ethanol extract or a butanol extract.
본 발명의 삼다차조 추출물은 모유두 세포의 증식을 증가시켜 탈모를 예방 또는 개선할 수 있다.The samda perilla extract of the present invention can prevent or improve hair loss by increasing the proliferation of dermal papilla cells.
본 발명의 삼다차조 추출물을 유효성분으로 포함하는 조성물은 모유두 세포의 증식을 촉진시켜 모발의 성장기를 유도하는 효과를 가지면서 부작용이 적어, 모발의 성장 또는 탈모의 개선에 효과적으로 사용될 수 있다.The composition containing the extract of Samdacha algae of the present invention as an active ingredient promotes the proliferation of dermal papilla cells to induce the growth phase of hair, while having few side effects, so it can be effectively used to improve hair growth or hair loss.
도 1은 삼다차조 70% 에탄올 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.
도 2는 삼다차조 헥산 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.
도 3은 삼다차조 에틸아세테이트 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.
도 4는 삼다차조 클로로포름 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.
도 5는 삼다차조 부탄올 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.
도 6은 삼다차조 열수 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.
도 7은 차조 70% 에탄올 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.
도 8은 차조 열수 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 1 shows the results of measuring the proliferation effect of dermal papilla cells for 70% ethanol extract of Samda perilla.
Figure 2 shows the results of measuring the proliferation effect of dermal papilla cells for the hexane extract of Samdachajo.
Figure 3 shows the results of measuring the proliferation effect of dermal papilla cells for the ethyl acetate extract of Samda perilla.
Figure 4 shows the results of measuring the proliferation effect of dermal papilla cells for the chloroform extract of Samda perilla.
Figure 5 shows the results of measuring the proliferation effect of dermal papilla cells for the butanol extract of Samda perilla.
Figure 6 shows the results of measuring the proliferation effect of dermal papilla cells on the hot water extract of Samdachajo.
Figure 7 shows the results of measuring the proliferation effect of dermal papilla cells for the perilla 70% ethanol extract.
Figure 8 shows the results of measuring the proliferation effect of dermal papilla cells on the perilla hot water extract.
이하, 첨부한 도면을 참조하여 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본원의 실시태양 및 실시예를 상세히 설명한다. 그러나 본원은 여러 가지 형태로 구현될 수 있으며 여기에서 설명하는 실시태양 및 실시예에 한정되지 않는다.Hereinafter, with reference to the accompanying drawings, embodiments and examples of the present disclosure will be described in detail so that those skilled in the art can easily practice the present invention. However, the present application may be implemented in various forms and is not limited to the embodiments and examples described herein.
본원 명세서 전체에서, 어떤 부분이 어떤 구성 요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성 요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다.Throughout the present specification, when a part "includes" a certain component, it means that it may further include other components without excluding other components unless otherwise stated.
본 발명은 삼다차조 추출물을 포함하는 탈모 예방 또는 개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for preventing or improving hair loss containing an extract of samda perilla.
본 발명의 "탈모"는, 그 원인과 무관하게, 정상적으로 모발이 존재해야 할 부위에 모발이 없는 상태를 지칭하며, 원형 탈모, 유전성 안드로겐 탈모, 휴지기 탈모, 외상성 탈모, 발모벽, 압박성 탈모, 생장기 탈모, 비강성 탈모, 매독성 탈모, 지루 탈모, 증후성 탈모, 반흔성 탈모 또는 선천성 탈모일 수 있으나, 이에 제한되지 않는다."Hair loss" of the present invention refers to a condition in which there is no hair in an area where hair should normally exist, regardless of the cause, and includes circular alopecia, hereditary androgenetic alopecia, telogen effluvium, traumatic alopecia, hair growth, pressure alopecia, It may be anagen hair loss, pityroid hair loss, syphilitic hair loss, seborrheic hair loss, symptomatic hair loss, scarring hair loss or congenital hair loss, but is not limited thereto.
본 발명의 삼다차조 (Setaria italica Beauv.)는 곡물인 조의 일종으로, 제주 지역에서 자생하는 토종 차조이며, 품종명은 삼다찰이다 (국립종자원 품종 참조). 본 발명에서는 제주도에서 자생하여 수확한 것인 삼다차조를 이용할 수 있으나 이에 한정되지 않는다.Samdachajo ( Setaria italica Beauv.) of the present invention is a kind of millet, which is a grain, and is a native perilla native to the Jeju region, and the breed name is Samdachal (see National Seed Resources). In the present invention, it is possible to use Samda tea, which is harvested from Jeju Island, but is not limited thereto.
본 발명의 삼다차조 추출물은 모유두 세포의 증식을 촉진하여 모발의 성장기를 유도함으로써, 탈모를 예방 또는 개선하는 효과를 나타낼 수 있다.The ginseng extract of the present invention promotes the proliferation of dermal papilla cells and induces the growth phase of hair, thereby exhibiting an effect of preventing or improving hair loss.
본 발명의 "예방"은 본 발명에 따른 조성물의 투여에 의해 탈모의 발병을 억제 또는 지연시키는 모든 행위를 의미하고, "개선"은 본 발명의 추출물을 포함하는 조성물의 투여로 치료되는 상태와 관련된 파라미터, 예를 들면 증상의 정도를 적어도 감소시키는 모든 행위를 의미한다."Prevention" of the present invention refers to any action that suppresses or delays the onset of hair loss by administration of the composition according to the present invention, and "improvement" is related to the condition treated by administration of the composition containing the extract of the present invention. Any action that at least reduces the severity of a parameter, eg a symptom.
본 발명의 "추출물"은 당업계에서 공지된 통상적인 추출용매를 이용하여 얻을 수 있다. 추출용매로는 극성 용매 또는 비극성 용매를 이용할 수 있다. 극성 용매로는 물, C1 내지 C6의 알코올 (예: 메탄올, 에탄올, 프로판올, 부탄올, 노말-프로판올, 이소-프로판올 및 노말-부탄올 등), 아세트산, 또는 상기 극성 용매들의 혼합물을 포함한다. 비극성 용매로는 아세톤, 아세토나이트릴, 에틸아세테이트, 메틸아세테이트, 부틸아세테이트, 플루오로알칸, 헥산, 에테르, 클로로포름, 디클로로메탄 또는 상기 비극성 용매들의 혼합물을 포함한다.The "extract" of the present invention can be obtained using a conventional extraction solvent known in the art. A polar solvent or a non-polar solvent may be used as the extraction solvent. Polar solvents include water, C1 to C6 alcohols (eg, methanol, ethanol, propanol, butanol, n-propanol, iso-propanol and n-butanol, etc.), acetic acid, or mixtures of the above polar solvents. Non-polar solvents include acetone, acetonitrile, ethyl acetate, methyl acetate, butyl acetate, fluoroalkanes, hexane, ether, chloroform, dichloromethane or mixtures of the above non-polar solvents.
일 실시태양에서, 상기 추출물은 물, C1 내지 C6의 알코올, 아세트산, 및 이들의 혼합 용매로 이루어지는 군으로부터 선택되는 용매로 추출된 것일 수 있다. 바람직하게는, 0.01% 내지 90% 에탄올 추출물 또는 부탄올 추출물이며, 더욱 바람직하게는 60% 내지 80% 에탄올 추출물 또는 부탄올 추출물이고, 가장 바람직하게는 70% 에탄올 추출물 또는 부탄올 추출물일 수 있다.In one embodiment, the extract may be extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, acetic acid, and a mixed solvent thereof. Preferably, it is 0.01% to 90% ethanol extract or butanol extract, more preferably 60% to 80% ethanol extract or butanol extract, and most preferably 70% ethanol extract or butanol extract.
본 발명의 추출물은 열수 추출, 냉침 추출, 환류 냉각 추출, 초음파 추출 또는 당업계에 알려진 통상적인 추출방법을 통해 추출한 것일 수 있다.The extract of the present invention may be extracted through hot water extraction, cold extraction, reflux cooling extraction, ultrasonic extraction, or a conventional extraction method known in the art.
본 발명에 사용된 용어 "추출물"은 당업계에서 조추출물 (crude extract)로 통용되는 것을 의미하지만, 광의적으로 추출물을 추가적으로 분획 (fractionation)한 분획물도 포함한다. 즉 추출물은 상술한 용매를 이용하여 얻은 것뿐만 아니라, 여기에 정제 과정을 추가적으로 적용하여 얻은 것을 포함한다. 예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외여과막을 통과시켜 얻은 분획, 다양한 크로마토그래프 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 생약 추출물에 포함된다.The term "extract" used in the present invention means what is commonly used as a crude extract in the art, but also includes a fraction obtained by additional fractionation of the extract in a broad sense. That is, the extract includes not only those obtained using the above-described solvent, but also those obtained by additionally applying a purification process thereto. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a certain molecular weight cut-off value, separation by various chromatographs (designed for separation according to size, charge, hydrophobicity or affinity), etc. Fractions obtained through the purification method are also included in the crude drug extract of the present invention.
본 발명의 화장료 조성물은 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형 (리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 포말 (foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition of the present invention is a solution, gel, solid or kneaded anhydrous product, emulsion obtained by dispersing an oil phase in an aqueous phase, suspension, microemulsion, microcapsule, microgranule or ionic (liposome), nonionic vesicle dispersant. , can be provided in the form of a cream, toner, lotion, powder, ointment, spray or conceal stick. In addition, it can be prepared in the form of a foam (foam) or the form of an aerosol composition further containing a compressed propellant.
또한, 상기 화장료 조성물은 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제 (foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition may include a fatty substance, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant, water, ionic or nonionic Cosmetics such as emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, humectants, essential oils, dyes, pigments, hydrophilic or lipophilic actives, lipid vesicles or any other ingredient commonly used in cosmetics It may contain adjuvants commonly used in the field.
본 발명의 화장료 조성물은 예를 들어, 모발용 화장품일 수 있다.The cosmetic composition of the present invention may be, for example, a hair cosmetic.
상기 모발용 화장료 조성물은 헤어샴푸, 헤어로션, 헤어컨디셔너, 헤어트리트먼트, 헤어토닉, 헤어에센스, 헤어세럼, 두피트리트먼트, 모발 영양화장수로 구성된 군으로부터 선택된 어느 하나의 제형으로 제조할 수 있으나, 제형화하는데 있어 특별히 한정하지 않는다. 또한, 각각의 제형에 있어 상기한 필수성분 이외에 다른 성분들은 기타 외용제의 종류 또는 사용목적 등에 따라 적절히 선택할 수 있다.The cosmetic composition for hair may be prepared in any one formulation selected from the group consisting of hair shampoo, hair lotion, hair conditioner, hair treatment, hair tonic, hair essence, hair serum, scalp treatment, and hair nutrient lotion. It is not particularly limited in making it. In addition, other ingredients in addition to the above essential ingredients in each formulation may be appropriately selected depending on the type of external preparation or purpose of use.
이하 실시예를 통하여 본 발명을 더욱 상세하게 설명하고자 하나, 하기의 실시예는 단지 설명의 목적을 위한 것이며 본원 발명의 범위를 한정하고자 하는 것은 아니다.The present invention will be described in more detail through the following examples, but the following examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
[실시예 1] [Example 1]
추출물의 제조Preparation of extract
삼다차조 70% 에탄올 추출물, 삼다차조 열수 추출물, 삼다차조 헥산 추출물, 삼다차조 에틸아세테이트 추출물, 삼다차조 클로로포름 추출물, 삼다차조 부탄올 추출물, 차조 70% 에탄올 추출물 및 차조 열수 추출물을 준비하였다.Samda-chajo 70% ethanol extract, Samda-chajo hot water extract, Samda-chajo hexane extract, Samda-chajo ethyl acetate extract, Samda-chajo chloroform extract, Samda-chajo butanol extract, Samda-chajo 70% ethanol extract, and Samda-chajo hot-water extract were prepared.
[실시예 2] [Example 2]
흰쥐 수염 모유두세포의 배양Culture of rat whisker dermal papilla cells
흰쥐 수염에서 분리된 모유두 세포를 불멸화한 세포 (Rat vibrissa immortalized dermal papilla cell: Filsell et al., 1994)를 100 units/mL penicillin-100 μg/mL streptomycin (Gibco Inc, NY, USA) 및 10% heat-inactivated fetal bovine serum (FBS; Gibco Inc, NY, USA)이 함유된 DMEM (Hyclone Inc, USA) 배지를 사용하여 37°C, 5% CO2 항온기에서 배양하였으며, 3일에 한 번씩 계대배양하였다.100 units/mL penicillin-100 μg/mL streptomycin (Gibco Inc, NY, USA) and 10% heat -Inactivated fetal bovine serum (FBS; Gibco Inc, NY, USA) containing DMEM (Hyclone Inc, USA) medium was used and cultured in a 37°C, 5% CO 2 incubator, and subcultured once every 3 days. .
[실시예 3] [Example 3]
삼다차조 70% 에탄올 (EtOH) 추출물에 대한70% Ethanol (EtOH) extract of Samdacha algae 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells
흰쥐 수염에서 분리된 모유두 세포를 불멸화한 세포 (Rat vibrissa immortalized dermal papilla cell)의 증식은 MTT assay를 이용하여 측정하였다. 모유두 세포 (1.0×104 cells/mL)를 1% FBS를 포함한 DMEM 배지에 혼탁하여 96 well plate에 넣고 24시간 배양하였다.Proliferation of rat vibrissa immortalized dermal papilla cells immortalized from dermal papilla cells isolated from rat whiskers was measured using the MTT assay. Dermal papilla cells (1.0×10 4 cells/mL) were turbid in DMEM medium containing 1% FBS, placed in a 96-well plate, and cultured for 24 hours.
삼다차조 70% 에탄올 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였다. 양성 대조군으로 미녹시딜 (minoxidil, Sigma, MO, USA) 10 μM 농도로 처리하였다. 48시간 동안 배양한 후 10 μL의 WST dye (Daeil Lab Service, Seoul, Korea)을 첨가하고 3시간 동안 반응시켰다. VERSAmax microplate reader (Molecular Devices, CA, USA)를 사용하여 450 nm에서 흡광도를 측정하였다. 시료군에 대한 평균 흡광도 값을 구하였으며, 대조군의 흡광도 값과 비교하여 증식 정도를 조사하여, 하기 표 1 및 도 1에 나타내었다.Samdachajo 70% ethanol extract was treated at concentrations of 1, 10 and 25 μg/mL. As a positive control, minoxidil (Sigma, MO, USA) was treated with 10 μM concentration. After culturing for 48 hours, 10 μL of WST dye (Daeil Lab Service, Seoul, Korea) was added and reacted for 3 hours. Absorbance was measured at 450 nm using a VERSAmax microplate reader (Molecular Devices, CA, USA). The average absorbance value for the sample group was obtained, and the degree of proliferation was investigated in comparison with the absorbance value of the control group, and is shown in Table 1 and FIG. 1 below.
상기 표 1 및 도 1에 나타낸 바와 같이, 삼다차조 70% EtOH 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 농도가 증가할수록 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 70% EtOH 추출물을 10 및 25 μg/mL 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과와 유사하거나 더 높은 모유두 세포 증식 효과를 나타내었다. As shown in Table 1 and FIG. 1, when the 70% EtOH extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells increased as the concentration increased. In particular, when Samda perilla 70% EtOH extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells significantly increased compared to the control group, and the dermal papilla cell proliferation effect was similar to or higher than the cell proliferation measurement result of the positive control group. showed
따라서, 삼다차조 70% 에탄올 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the 70% ethanol extract of Samdachajo has a dermal papilla cell proliferation effect.
[실시예 4] [Example 4]
삼다차조 헥산 (hexane) 추출물에 대한About Samdacha hexane extract 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells
상기 실시예 3과 동일한 방법으로 삼다차조 헥산 추출물에 대한 모유두 세포 증식 효과에 대해 실험을 수행하여, 하기 표 2 및 도 2에 나타내었다.Experiments were performed on the dermal papilla cell proliferation effect of the Samda perilla hexane extract in the same manner as in Example 3, and are shown in Table 2 and FIG. 2 below.
상기 표 2 및 도 2에 나타낸 바와 같이, 삼다차조 hexane 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 hexane 추출물을 10 및 25 μg/mL의 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 2 and FIG. 2, it was confirmed that the proliferation of dermal papilla cells increased when the hexane extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL. In particular, when the hexane extract of Samda perilla extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells significantly increased compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than that of the positive control group. was
따라서, 삼다차조 헥산 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the hexane extract of Samdachajo has the dermal papilla cell proliferation effect.
[실시예 5] [Example 5]
삼다차조 에틸아세테이트 (EtOAc) 추출물에 대한Ethyl acetate (EtOAc) extract of Samdachazo 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells
상기 실시예 3과 동일한 방법으로 삼다차조 에틸아세테이트 추출물에 대한 모유두 세포 증식 효과에 대해 실험을 수행하여, 하기 표 3 및 도 3에 나타내었다.In the same manner as in Example 3, experiments were performed on the dermal papilla cell proliferation effect of the extract of Samda perilla ethyl acetate, and are shown in Table 3 and FIG. 3 below.
상기 표 3 및 도 3에 나타낸 바와 같이, 삼다차조 EtOAc 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 EtOAc 추출물을 10 및 25 μg/mL의 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 3 and FIG. 3, when the EtOAc extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells increased. In particular, when the EtOAc extract of Samda perilla extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells significantly increased compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than that of the positive control group. was
따라서, 삼다차조 에틸아세테이트 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the ethyl acetate extract of Samdachajo has an effect on dermal papilla cell proliferation.
[실시예 6] [Example 6]
삼다차조 클로로포름 (CHClTertiary chloroform (CHCl 33 ) 추출물에 대한) for extract 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells
상기 실시예 3과 동일한 방법으로 삼다차조 클로로포름 추출물에 대한 모유두 세포 증식 효과에 대해 실험을 수행하여, 하기 표 4 및 도 4에 나타내었다.In the same manner as in Example 3, experiments were performed on the dermal papilla cell proliferation effect of the chloroform extract of Samda perilla extract, and are shown in Table 4 and FIG. 4 below.
상기 표 4 및 도 4에 나타낸 바와 같이, 삼다차조 CHCl3 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 CHCl3 추출물을 10 및 25 μg/mL의 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 4 and FIG. 4, when the extract of Samdachajo CHCl 3 was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells increased. In particular, when the Samda perilla CHCl 3 extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells was significantly increased compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than the cell proliferation measurement result of the positive control group. showed up
따라서, 삼다차조 클로로포름 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the chloroform extract of Samda perilla has the dermal papilla cell proliferation effect.
[실시예 7] [Example 7]
삼다차조 부탄올 (BuOH) 추출물에 대한About Samdachazo Butanol (BuOH) Extract 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells
상기 실시예 3과 동일한 방법으로 삼다차조 부탄올 추출물에 대한 모유두 세포 증식 효과에 대해 실험을 수행하여, 하기 표 5 및 도 5에 나타내었다.In the same manner as in Example 3, experiments were performed on the dermal papilla cell proliferation effect of the butanol extract of Samda perilla extract, and are shown in Table 5 and FIG. 5 below.
상기 표 5 및 도 5에 나타낸 바와 같이, 삼다차조 BuOH 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 농도가 증가할수록 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 BuOH 추출물을 10 및 25 μg/mL의 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 5 and FIG. 5, when the BuOH extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells increased as the concentration increased. In particular, when the Samda perilla BuOH extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells was significantly increased compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than the cell proliferation measurement result of the positive control group. was
따라서, 삼다차조 부탄올 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the butanol extract of Samdachajo has the dermal papilla cell proliferation effect.
[비교예 1] [Comparative Example 1]
삼다차조 열수 추출물에 대한About Samdachazo Hot Water Extract 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells
상기 실시예 3과 동일한 방법으로 삼다차조 열수 추출물에 대한 모유두 세포 증식 효과에 대한 실험을 수행하여, 하기 표 6 및 도 6에 나타내었다.In the same manner as in Example 3, an experiment was performed on the dermal papilla cell proliferation effect of the hot water extract of Samdacha algae, and the results are shown in Table 6 and FIG. 6 below.
상기 표 6 및 도 6에 나타낸 바와 같이, 삼다차조 열수 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식에 영향을 미치지 않는 것을 확인하였다. As shown in Table 6 and FIG. 6, it was confirmed that the proliferation of dermal papilla cells was not affected when the hot water extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL.
[비교예 2] [Comparative Example 2]
차조 70% 에탄올 추출물에 대한About Perilla 70% Ethanol Extract 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells
상기 실시예 3과 동일한 방법으로 차조 70% 에탄올 추출물에 대한 모유두 세포 증식 효과에 대한 실험을 수행하여, 하기 표 7 및 도 7에 나타내었다.Experiments on the dermal papilla cell proliferation effect of the 70% ethanol extract of perilla perilla in the same manner as in Example 3 were performed, and are shown in Table 7 and FIG. 7 below.
상기 표 7 및 도 7에 나타낸 바와 같이, 차조 70% EtOH 추출물을 1 및 10 μg/mL 농도로 처리하였을 때 모유두 세포의 증식을 증가시키는 것을 확인하였으나, 차조 70% EtOH 추출물을 25 μg/mL 농도로 처리하였을 때 저농도로 처리한 것과 비교하여 모유두 세포의 증식이 오히려 감소하는 것을 확인하였다.As shown in Table 7 and FIG. 7, it was confirmed that the proliferation of dermal papilla cells was increased when the 70% EtOH extract of perilla was treated at concentrations of 1 and 10 μg/mL, but the 70% EtOH extract of perilla at 25 μg/mL concentration When treated with, it was confirmed that the proliferation of dermal papilla cells rather decreased compared to that treated with a low concentration.
[비교예 3] [Comparative Example 3]
차조 열수 추출물에 대한About Perilla Hot Water Extract 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells
상기 실시예 3과 동일한 방법으로 차조 열수 추출물에 대한 모유두 세포 증식 효과에 대한 실험을 수행하여, 하기 표 8 및 도 8에 나타내었다.Experiments on the dermal papilla cell proliferation effect of the perilla hot water extract were performed in the same manner as in Example 3, and are shown in Table 8 and FIG. 8 below.
상기 표 8 및 도 8에 나타낸 바와 같이, 차조 열수 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식에 영향을 미치지 않는 것을 확인하였다. As shown in Table 8 and FIG. 8, when the perilla hot water extract was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells was not affected.
Claims (7)
A cosmetic composition for preventing or improving hair loss comprising a samda perilla extract.
The prevention or improvement of hair loss according to claim 1, wherein the extract of Samdachajo is extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, ethyl acetate, hexane, chloroform, and mixed solvents thereof Cosmetic composition for.
The cosmetic composition for preventing or improving hair loss according to claim 1, wherein the extract of Samdachajo is 0.01% to 90% ethanol extract.
The cosmetic composition for the prevention or improvement of hair loss according to claim 1, wherein the samda perilla extract is a 60% to 80% ethanol extract.
The cosmetic composition for the prevention or improvement of hair loss according to claim 1, wherein the samda perilla extract is a 70% ethanol extract.
The cosmetic composition for preventing or improving hair loss according to claim 1, wherein the samda perilla extract is a butanol extract.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210134094A KR102622831B1 (en) | 2021-10-08 | 2021-10-08 | A composition for prevention or improvement of hair loss comprising setaria italica beauv. extract |
CN202280067460.9A CN118434407A (en) | 2021-10-08 | 2022-10-05 | Composition for preventing or improving alopecia comprising extract of Murraya koenigii |
PCT/KR2022/014966 WO2023059053A1 (en) | 2021-10-08 | 2022-10-05 | Composition for preventing or alleviating hair loss, comprising extract of samda glutinous foxtail millet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210134094A KR102622831B1 (en) | 2021-10-08 | 2021-10-08 | A composition for prevention or improvement of hair loss comprising setaria italica beauv. extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230050829A true KR20230050829A (en) | 2023-04-17 |
KR102622831B1 KR102622831B1 (en) | 2024-01-09 |
Family
ID=85803611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210134094A KR102622831B1 (en) | 2021-10-08 | 2021-10-08 | A composition for prevention or improvement of hair loss comprising setaria italica beauv. extract |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR102622831B1 (en) |
CN (1) | CN118434407A (en) |
WO (1) | WO2023059053A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080032127A (en) * | 2005-08-12 | 2008-04-14 | 켄지 코노 | Agent for hair growth |
KR20190037777A (en) * | 2017-09-29 | 2019-04-08 | 유씨엘 주식회사 | Cosmetic composition for preventing seborrheic dematitis and hair loss |
KR102150927B1 (en) | 2018-12-31 | 2020-09-02 | 대봉엘에스 주식회사 | Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006053415A1 (en) * | 2004-11-18 | 2006-05-26 | Biopharmacopae Design International Inc. | Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof |
KR102160535B1 (en) * | 2019-01-22 | 2020-09-28 | 이동완 | Compositions for promoting hair growth or preventing hair loss comprising a complex extract of cucumber, eggplant and snail |
KR102242151B1 (en) * | 2019-07-24 | 2021-05-17 | 주식회사 바이오원코리아 | Food composition for hair-loss and hair-growth comprising herbal medicine and preparation method thereof |
-
2021
- 2021-10-08 KR KR1020210134094A patent/KR102622831B1/en active IP Right Grant
-
2022
- 2022-10-05 CN CN202280067460.9A patent/CN118434407A/en active Pending
- 2022-10-05 WO PCT/KR2022/014966 patent/WO2023059053A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080032127A (en) * | 2005-08-12 | 2008-04-14 | 켄지 코노 | Agent for hair growth |
KR20190037777A (en) * | 2017-09-29 | 2019-04-08 | 유씨엘 주식회사 | Cosmetic composition for preventing seborrheic dematitis and hair loss |
KR102150927B1 (en) | 2018-12-31 | 2020-09-02 | 대봉엘에스 주식회사 | Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea |
Also Published As
Publication number | Publication date |
---|---|
KR102622831B1 (en) | 2024-01-09 |
WO2023059053A1 (en) | 2023-04-13 |
CN118434407A (en) | 2024-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101698922B1 (en) | Composition for promoting hair growth and restoration | |
US10967028B2 (en) | Composition for hair loss prevention or hair growth stimulation comprising Artemisia umbelliformis extract | |
JP6860558B2 (en) | Hair growth and / or hair growth promoting composition containing soyasaponin | |
JP2023534287A (en) | Composition for preventing hair loss and promoting hair growth | |
US10568830B2 (en) | Composition for hair loss prevention or hair growth stimulation comprising Scutellaria alpina extract | |
KR20180082351A (en) | A composition for promotion of hair growth comprising extracts of Eclipta prostrata | |
CN107898656B (en) | Skin external composition containing ginsenoside RF | |
US9572765B2 (en) | Composition for preventing hair loss or promoting hair restoration, comprising soy extract | |
KR20230050829A (en) | A composition for prevention or improvement of hair loss comprising setaria italica beauv. extract | |
KR20050102346A (en) | Hair growth agent composition | |
KR102255264B1 (en) | Composition for preventing hair loss and promoting hair growth comprising extract of the aerial parts of carrot | |
CN111107867B (en) | Composition for preventing alopecia or promoting hair growth comprising brain protecting agent | |
KR101909533B1 (en) | Composition of skin external application containing ginsenoside F1 | |
KR20050077310A (en) | Hair and eyebrow, eyelashes growth stimulater using indigo extracts | |
KR102684917B1 (en) | A composition for prevention or treatment of hair loss comprising setaria italica beauv. extract | |
KR102406692B1 (en) | Composition for promoting hair growth comprising germinated gemmule of bean | |
KR20150025984A (en) | Composition for promoting hair growth or restoration containing 21-o-angeloyltheasapogenol e3 | |
KR20130055274A (en) | Composition for growth promotion and proliferation of hair comprising eucheuma cottonii extracts as effective ingredient | |
KR20100094433A (en) | Composition comprising extracts of rubus coreanum miquel | |
KR20160116721A (en) | Composition for prevention of hair loss or promotion of hair growth containing assam extract and/or isodon japonicus extract | |
KR20230076422A (en) | Composition for treating or preventing alopecia comprising decursin | |
KR20240006421A (en) | A composition for improving, preventing and treating of hair loss, promoting hair growth comprising Justicia procumbens extract | |
KR101821955B1 (en) | Process For Preparation Of Composition For Improving Hair Health | |
CN107970251B (en) | Skin external composition containing ginsenoside Mc | |
KR20220162555A (en) | Composition for preventing hair loss and promoting hair growth comprising Gypsophila paniculata |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |